yingweiwo

ERR

ERR

Estrogen receptors are a group of proteins found inside cells.They are receptors that the estrogen (17-estradiol) hormone activates. There are two classes of estrogen receptors: GPER (GPR30), a member of the rhodopsin-like family of G protein-coupled receptors, and ER, a member of the nuclear hormone family of intracellular receptors. The interactions between coactivators and corepressors, and consequently, the agonist or antagonist effect of the ligand, are heavily influenced by the ER's helix 12 domain.Different ligands may have different affinities for the estrogen receptor's alpha and beta isoforms. Estradiol binds to both receptors equally well, however raloxifene, estrone, and genistein bind preferentially to the alpha receptor. In addition to being necessary for sexual maturation and reproductive function, estrogen and its receptors also affect other tissues, like bone. In pathological conditions like osteoporosis, endometrial cancer, and breast cancer, estrogen receptors play a role. Numerous transcript variations are produced by alternative promoter use and alternative splicing, however it is unknown how many of these variants are full-length.

ERR related products

Structure Cat No. Product Name CAS No. Product Description
Corifollitropin alfa (Org 36286; MK-8962) V67668 Corifollitropin alfa (Org 36286; MK-8962) 195962-23-3 Corifollitropin alfa (Org 36286) is a long-acting recombinant follicle-stimulating hormone (FSH) analogue.
Dehydrodiconiferyl alcohol V67690 Dehydrodiconiferyl alcohol 4263-87-0 Dehydrodiconiferyl alcohol is an estrogen receptor agonist that can promote BMP-2-induced osteoblastogenesis.
Dienestrol V19820 Dienestrol 84-17-3 Dienestrol is a synthetic, non-steroidal estrogen acting as an estrogen receptor agonist for the treatment of menopausal and postmenopausal symptoms.
Diethylstilbestrol-d8 (Stilbestrol-d8) V67676 Diethylstilbestrol-d8 (Stilbestrol-d8) 91318-10-4 Diethylstilbestrol-d8 is the deuterium labelled form of Diethylstilbestrol.
Droloxifene (3-Hydroxytamoxifen) V20253 Droloxifene (3-Hydroxytamoxifen) 82413-20-5 Droloxifene (3-Hydroxytamoxifen) is a tamoxifen analogue and orally bioactive SERM (selective estrogen receptor modulator) that acts as an ER agonist in bone and as an ER antagonist in breast tissue.
DS20362725 V67724 DS20362725 2735803-20-8 DS20362725 is an estrogen-related receptor alpha (ERRα) agonist.
DS45500853 V67723 DS45500853 2735803-28-6 DS45500853 is an estrogen-related receptor alpha (ERRα) agonist.
DY131 V2996 DY131 95167-41-2 DY131 (also known as GSK-9089) is a novel selective agonist at estrogen-related receptors ERRβ and ERRγ with minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM.
E3 ligase Ligand 5 V4061 E3 ligase Ligand 5 1264754-13-3 E3 ligase Ligand 5 is an E3 ligase Ligand that can be used in the synthesis of PROTACs (proteolysis targeting chimeras) to engage an E3 ubiquitin ligase.
Elacestrant (S enantiomer) (RAD1901 S enantiomer) V67660 Elacestrant (S enantiomer) (RAD1901 S enantiomer) 2309762-29-4 Elacestrant S enantiomer (RAD1901 S enantiomer) is the less active enantiomer of Elacestrant.
Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride) V67663 Elacestrant S enantiomer dihydrochloride (RAD1901 S enantiomer dihydrochloride) 2309762-30-7 Elacestrant S enantiomer di-HCl (RAD1901 S enantiomer di-HCl) is the less active enantiomer of Elacestrant.
Enclomiphene citrate V19199 Enclomiphene citrate 7599-79-3 Enclomiphene citrate, formerly known as ICI-46476, RMI-16289 and trans-Clomiphene, is an orally bioavailable non-steroidal estrogen receptor antagonist in development for secondary hypogonadism in overweight men wishing to restore normal testicular function.
Endoxifen V33910 Endoxifen 110025-28-0 Endoxifen, an active metabolite of Tamoxifen, is a potent and selective estrogen receptor antagonist and has been found to be effective in patients that have failed previous hormonal therapies.
Endoxifen E-isomer HCl V20552 Endoxifen E-isomer HCl 1197194-61-8 Endoxifen E-isomer HCl (E-Endoxifen HCl) is the E-isomer of Endoxifen and is the main impurity in the raw material of Endoxifen Z-isomer.
Endoxifen Z-isomer V5719 Endoxifen Z-isomer 112093-28-4 Endoxifen Z-isomer is an active metabolite of Tamoxifen metabolite responsible for eliciting the anti-estrogenic effects of this drug in breast cancer cells expressing estrogen receptor-alpha (ERα).
Equilin (7-Dehydroestrone) V30482 Equilin (7-Dehydroestrone) 474-86-2 Equilin (7-Dehydroestrone) is an important member of a large family of estrogenic substances that is chemically related to estradiol.
Equilin-d4 (7-Dehydroestrone-d4) V67703 Equilin-d4 (7-Dehydroestrone-d4) 285979-79-5 Equilin-d4 is the deuterium labelled form of Equilin.
Equol (racemic) V28146 Equol (racemic) 94105-90-5 Equol (racemic), the racemic mixture of equol,is a drug is potentially for the treatment of acute thyroid disease and inhibits proliferation of human gastric carcinoma cells.
ER degrader 4 V67678 ER degrader 4 2913192-39-7 ER degrader 4 is a selective and orally bioactive estrogen receptor degrader.
ER degrader 5 V67679 ER degrader 5 2913192-47-7 ER degrader 5 is a potent estrogen receptor (ER) degrader.
Contact Us